Survey on the unmet needs for patients living with metastatic colorectal cancer

Colorectal cancer (CRC) as compared to breast, lung, and prostate cancers, represents more than 50% of cancer incidence in Europe. An early detection of cancer has been shown to reduce the mortality from colorectal cancer. The plasmonic devices developed in ULTRAPLACAD will allow a non-invasive early diagnosis of the disease. To better understand the needs of patients and procedures for diagnosis, prognosis and therapy efficacy assessment, the ULTRAPLACAD project is supporting the initiatives of EuropaColon association, including the survey on the unmet needs for patients living with metastatic CRC. You can participate to the survey at the following link: http://www.europacolon.com/survey.php?Action=Survey ​​​​​​​